TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Indonesia facing shortage of pharmacoeconomists
Indonesia still lacked experts in the field of pharmacoeconomics, a scientific discipline that compares the value of one pharmaceutical drug or drug therapy with another, an official noted Sunday
Change Size
I
ndonesia still lacked experts in the field of pharmacoeconomics, a scientific discipline that compares the value of one pharmaceutical drug or drug therapy with another, an official noted Sunday.
"We still have very few pharmacoeconomists, while our neighbors Malaysia and Singapore have many experts in pharmacoeconomics," president of the Indonesian chapter of the International Society for Pharmacoeconomics Outcome Research (ISPOR), Ahmad Fuad Afdhal, said in Denpasar on Sunday as quoted by Antara news agency.
He said that Indonesia needed many more pharmacoeconomists, whose research would contribute to providing efficient and inexpensive health services in the country.
Fuad pointed out, however, that in three years since the establishment of the ISPOR in Indonesia, pharmacologists had begun focusing on pharmacoeconomics.
"Three years since ISPOR was established, it has published guidebooks on pharmacoeconomic research and launched the pharmacoeconomic program at the University of Indonesia's public health school," he remarked.
A pharmacoeconomic evaluation is an analytical tool increasingly used to assist decision-making surrounding the financing and management of pharmaceutical products in healthcare systems or national health insurance programs.
Pharmacoeconomic guidelines can be used as a standard for the preparation of studies to be included in the application for reimbursements, a guide for designing and conducting studies or a template for evaluating economic reports.(hhr)
